Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Issue 10 (1st April 2014)

• Record Type: Journal Article
• Authors: Kiire, Christine A; Mukherjee, Rajarshi; Ruparelia, Neil; Keeling, David; Prendergast, Bernard; Norris, Jonathan H
• Is Part Of: British journal of ophthalmology. Volume 98:Issue 10(2014)
• Page Start: 1320
• Page End: 1324
• Publication Date: 2014-04-01
• Subjects: Treatment Surgery -- Diagnostic tests/Investigation -- Biochemistry; Ophthalmology -- Periodicals; 617.7
• DOI: 10.1136/bjophthalmol-2014-304902
• Languages: English
• ISSNs: 0007-1161

Abstract

Abstract : The management of antiplatelet and anticoagulant treatment can be challenging for the ophthalmic surgeon with the risk of impaired surgical view or potentially sight-threatening haemorrhage. With the advent of newer medications and the expanding usage of these drugs, there is a need for up-to-date guidance on the subject. This paper describes the current use of modern antiplatelet and anticoagulant drugs in the UK, and reviews the evidence of such treatments in the context of ophthalmic surgery. A multidisciplinary approach has been used to develop a guideline for the management of antiplatelet and anticoagulation treatment in elective ophthalmic surgery. Specifically, guidance is provided on when and how to stop antiplatelet and anticoagulant treatment and, importantly, when to seek specialist medical advice.